Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Favrille Series B Gets $16.9M To Pay For Ongoing Studies

June 12, 2002

Gilead, Anadys Enter Deal For HTP With Viral Target

June 11, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.